YOLFTbeta
AViTA Corporation

AViTA Corporation

4735 · TWO · Healthcare / Medical Devices

35.10TWD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close35.10
Open35.10
Day Range34.70 – 35.45
52-Week Range29.00 – 40.80
Volume21.75K
Market Cap1.39B
P/E (TTM)5.95
Forward P/E0.00
EPS6.05
Dividend Yield16.67%
Beta0.34
50-Day Avg35.62
200-Day Avg32.44

About

AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation was founded in 1996 and is headquartered in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Qiang Ji
  • Employees0
  • HeadquartersNo.78, Kwang-Fu Road, New Taipei City, Taiwan, 24158, Taiwan
  • Websitehttps://www.avita.com.tw

Leadership

  • Mr. Qiang JiGM & Vice Chairman
  • Mr. Zhong Jie ZhuangChief Financial Officer
  • Qiu Gui ChenAccounting Supervisor
  • Mr. Yang-Xing OuCTO and Senior VP of R&D

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.13B1.33B1.25B2.60B2.33B1.20B879.08M927.30M936.39M
Growth (%)-+16.95%-5.97%+108.41%-10.57%-48.35%-26.80%+5.48%+0.98%
Cost of Revenue835.51M993.32M856.65M1.66B1.65B844.10M614.29M672.71M640.66M
Gross Profit299.01M333.51M390.94M940.43M674.50M356.81M264.79M254.59M295.73M
Gross Margin26.36%25.14%31.34%36.17%29.01%29.71%30.12%27.45%31.58%
Operating Expense183.32M203.31M214.16M288.98M278.22M218.79M220.72M239.00M249.36M
Operating Income115.69M130.20M176.78M651.45M396.28M138.03M44.07M15.59M46.37M
Operating Margin10.20%9.81%14.17%25.05%17.04%11.49%5.01%1.68%4.95%
EBITDA147.06M156.18M207.51M694.77M468.49M206.71M104.92M125.63M154.52M
EBITDA Margin12.96%11.77%16.63%26.72%20.15%17.21%11.94%13.55%16.50%
Net Income103.19M98.82M130.95M520.07M315.47M101.13M42.72M57.88M93.19M
Net Income Margin9.10%7.45%10.50%20.00%13.57%8.42%4.86%6.24%9.95%
R&D40.85M46.83M51.68M58.99M70.68M73.45M87.62M76.12M93.02M
R&D as % of Total Revenue3.60%3.53%4.14%2.27%3.04%6.12%9.97%8.21%9.93%
Interest Expense05.69M6.09M2.50M4.44M1.57M2.86M3.69M467.00K
Interest Expense % of Total Revenue0.00%0.43%0.49%0.10%0.19%0.13%0.33%0.40%0.05%

Balance Sheet

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets982.28M1.08B1.04B2.53B1.69B1.34B1.24B1.19B1.35B
Total Liabilities537.17M656.16M515.72M1.62B742.75M426.61M350.80M352.93M358.63M
Total Equity445.11M422.85M525.49M909.43M952.03M911.18M888.28M838.11M996.01M
Cash165.00M263.31M278.37M528.38M292.93M394.45M424.07M434.15M267.16M
Total Debt---474.37M299.55M77.34M46.16M--
Net Debt88.03M33.11M--54.01M6.62M-317.11M-377.90M--

Cash Flow

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-160.55M107.78M231.81M406.31M237.01M490.50M212.02M192.52M64.46M
Investing Cash Flow--233.75M60.01M-50.86M-226.00M-53.48M-75.08M---
Financing Cash Flow-92.25M-73.04M-166.87M74.43M-416.47M-318.95M-93.77M--
Capital Expenditure0118.79M31.86M44.35M197.88M71.93M65.31M31.28M83.79M262.16M
Free Cash Flow-40.92M74.60M187.21M208.43M165.08M425.19M180.74M108.73M-197.70M
Dividends Paid-65.15M73.00M71.63M317.06M298.84M91.92M54.91M15.57M89.64M
FCF to OCF-25.49%69.22%80.76%51.30%69.65%86.68%85.24%56.48%-306.70%
Dividend Paid to FCF-159.22%97.85%38.26%152.12%181.03%21.62%30.38%14.32%-45.34%

Earnings

Report DateNov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 14, 2014Aug 12, 2014Nov 13, 2014Mar 30, 2015May 14, 2015Aug 14, 2015Nov 12, 2015Mar 28, 2016Apr 1, 2016Aug 12, 2016Nov 11, 2016Mar 22, 2017May 11, 2017Aug 9, 2017Nov 10, 2017Mar 28, 2018May 14, 2018Aug 13, 2018Nov 11, 2018Mar 25, 2019May 3, 2019Aug 13, 2019Nov 12, 2019Mar 27, 2020May 11, 2020Aug 11, 2020Nov 11, 2020Mar 12, 2021May 7, 2021Aug 6, 2021Nov 5, 2021Mar 18, 2022Jun 1, 2022Aug 12, 2022Nov 4, 2022Mar 17, 2023May 5, 2023
EPS Estimate-------0.220.17-0.300.520.790.520.640.63-1.01-0.541.191.000.650.760.861.510.361.001.341.530.551.673.905.55---------
EPS Actual0.01-0.32-0.310.38-0.56-0.610.030.190.290.320.230.330.700.600.710.200.801.030.650.751.030.690.330.600.571.410.770.841.350.880.912.416.205.174.892.041.020.700.650.620.960.520.67
Surprise--------13.64%70.59%--23.33%-36.54%-11.39%15.38%10.94%-68.25%-1.98%-38.89%-13.45%-31.00%-49.23%-21.05%-33.72%-6.62%113.89%-16.00%0.75%-42.48%65.45%44.31%58.97%-6.85%---------
Timing------Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market-After-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap1.39B
Enterprise Value956.52M
Trailing P/E5.95
Forward P/E0.00
Price / Sales1.43
Price / Book1.22
EPS6.05
Book Value29.36
Revenue (TTM)972.61M
Gross Profit (TTM)306.90M
EBITDA104.73M
Profit Margin23.80%
Operating Margin10.37%
Return on Equity22.64%
Return on Assets2.19%
Shares Outstanding38.51M
Shares Float20.92M
Beta0.34
Dividend Yield16.67%
Dividend Rate6.00
Payout Ratio42.96%

Dividends

20263×
1.50Aug 31, 20261.00Jun 15, 20260.50Apr 10, 2026
20254×
0.70Dec 2, 20250.40Aug 28, 20250.41Jun 10, 20250.80Apr 10, 2025
20241×
0.45Nov 28, 2024
20233×
0.50Aug 31, 20230.50Jun 8, 20230.50Apr 6, 2023
20224×
0.50Dec 6, 20220.50Sep 7, 20220.50Jun 16, 20221.00Apr 14, 2022
20214×
1.20Nov 23, 20212.49Sep 23, 20211.49Jul 6, 20212.99Mar 31, 2021
20202×
5.98Nov 30, 20202.69Jul 13, 2020
20191×
2.29Jul 25, 2019
20181×
2.26Jul 16, 2018
20171×
2.00Jul 3, 2017